RT Journal Article SR Electronic T1 Effects of Immunomodulators and Biologic Agents on Sexual Health in Patients With Inflammatory Bowel Disease JF Ochsner Journal JO Ochsner J FD O. P. Jindal Global University SP 150 OP 156 VO 17 IS 2 A1 Ozdemir Kanar A1 Andrew C. Berry A1 Rahman Nakshabendi A1 Ann Joo Lee A1 Petra Aldridge A1 Travis Myers A1 Emely Eid YR 2017 UL http://www.ochsnerjournal.org/content/17/2/150.abstract AB Background: Although much knowledge has been gained regarding the medical and surgical management of inflammatory bowel disease (IBD), a paucity of information is available on the psychosexual issues related to IBD. The aim of this study was to evaluate the sexual health of patients with IBD who were taking immunomodulators and/or biologic agents vs patients with IBD who were not on that medication regimen.Methods: All study participants completed a validated sexual health questionnaire, the Female Sexual Function Index or the International Index of Erectile Function, to assess their subjective perception of the effect of IBD on the different domains of sexual function during the prior 1-month time period.Results: No statistically significant differences in any baseline demographic variables were found for either sex between the group taking immunomodulators/biologic agents and the nontreatment group. Among females and males, individual question responses, domain scores, and total scores showed no statistically significant differences between the 2 treatment groups.Conclusion: Our data suggest that the use of immunomodulators or biologic agents does not affect female or male sexual health. However, treatment of patients with IBD must be individualized based on the aggressive nature of the disease, treatment goals, and the tolerability of various medications.